{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:27:13Z","timestamp":1778066833891,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T00:00:00Z","timestamp":1101427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s10067-004-1002-8","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T07:08:12Z","timestamp":1101366492000},"page":"251-257","source":"Crossref","is-referenced-by-count":38,"title":["High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener\u2019s granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide"],"prefix":"10.1007","volume":"24","author":[{"given":"E.","family":"Benenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W. U.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Heilig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pollok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rubbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,26]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K, Bacon P et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"1002_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003495-200363020-00004","volume":"63","author":"DG Kuiper-Geertsma","year":"2003","unstructured":"Kuiper-Geertsma DG, Derksen RH (2003) Newer drugs for the treatment of lupus nephritis. Drugs 63:167\u2013180","journal-title":"Drugs"},{"key":"1002_CR3","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/0016-5085(95)90747-5","volume":"109","author":"WJ Sandborn","year":"1995","unstructured":"Sandborn WJ, Van Os EC, Zins BJ et al (1995) An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn disease. Gastroenterology 109:1808\u20131817","journal-title":"Gastroenterology"},{"key":"1002_CR4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0016-5085(99)70445-2","volume":"117","author":"WJ Sandborn","year":"1999","unstructured":"Sandborn WJ, Tremaine WJ, Wolf DC et al (1999) Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn\u2019s disease. Gastroenterology 117:527\u2013535","journal-title":"Gastroenterology"},{"key":"1002_CR5","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1111\/j.1572-0241.2000.03362.x","volume":"95","author":"U Maxavedan","year":"2000","unstructured":"Maxavedan U, Tremaine WJ, Johnson T et al (2000) Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol 95:3463\u20133468","journal-title":"Am J Gastroenterol"},{"key":"1002_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/rheumatology\/39.2.182","volume":"39","author":"P Durez","year":"2000","unstructured":"Durez P, Horsmas Y (2000) Dramatic response after an intravenous loading dose of azathioprine in one case of severe and refractory ankylosing spondylitis. Rheumatology 39:182\u2013184","journal-title":"Rheumatology"},{"key":"1002_CR7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/rheumatology\/39.12.1435","volume":"39","author":"A Pickenpack","year":"2000","unstructured":"Pickenpack A, Straub RH, Distler O et al (2000) Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases. Rheumatology 39:1435\u20131436","journal-title":"Rheumatology"},{"key":"1002_CR8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1529-0131(199901)42:1<186::AID-ANR23>3.0.CO;2-Y","volume":"42","author":"EL Matteson","year":"1999","unstructured":"Matteson EL, Orces CH, Duddy J et al (1999) Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis. Arthritis Rheum 42:186\u2013187","journal-title":"Arthritis Rheum"},{"key":"1002_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"1002_CR10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"1002_CR11","first-page":"671","volume":"87","author":"RA Lugmani","year":"1994","unstructured":"Lugmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671\u2013678","journal-title":"QJM"},{"key":"1002_CR12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","volume":"43","author":"E Reinhold-Keller","year":"2000","unstructured":"Reinhold-Keller E, Beuge N, Latza U et al (2000) An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis. Arthritis Rheum 43:1021\u20131032","journal-title":"Arthritis Rheum"},{"key":"1002_CR13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"1002_CR14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1994.70","volume":"45","author":"HA Austin","year":"1994","unstructured":"Austin HA, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histological data. Kidney Int 45:544\u2013551","journal-title":"Kidney Int"},{"key":"1002_CR15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Glaman DD, Urowitz MW et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"1002_CR16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00007691-199606000-00002","volume":"18","author":"E Sch\u00fctz","year":"1996","unstructured":"Sch\u00fctz E, Gummert J, Mohr FM et al (1996) Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine. Ther Drug Monit 18:228\u2013233","journal-title":"Ther Drug Monit"},{"key":"1002_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002281-199901000-00007","volume":"11","author":"WL Gross","year":"1999","unstructured":"Gross WL (1999) New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol 11:41\u201346","journal-title":"Curr Opin Rheumatol"},{"key":"1002_CR18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","volume":"14","author":"R Birck","year":"2003","unstructured":"Birck R, Warnatz K, Lorenz HM et al (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-months open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14:440\u2013447","journal-title":"J Am Soc Nephrol"},{"key":"1002_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Uhlfelder ML, Hellmann DB et al (2001) Etanercept combined with conventional treatment in Wegener\u2019s granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 44:1149\u20131154","journal-title":"Arthritis Rheum"},{"issue":"Suppl l","key":"1002_CR20","first-page":"109","volume":"62","author":"A Gause","year":"2003","unstructured":"Gause A, Arbach O, Reinhold-Keller E et al (2003) Infliximab zur Remissions-induktion bei aktiver generalisierter Wegener\u2019scher Granulomatose: Infekti\u00f6se Komplikationen. Z Rheumatol 62 [Suppl l]:109","journal-title":"Z Rheumatol"},{"key":"1002_CR21","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","volume":"44","author":"U Specks","year":"2001","unstructured":"Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener\u2019s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44:2836\u20132840","journal-title":"Arthritis Rheum"},{"key":"1002_CR22","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","volume":"46","author":"MJ Leonardo","year":"2002","unstructured":"Leonardo MJ, Edwards JC, Cambridge G et al (2002) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 46:2673\u20132677","journal-title":"Arthritis Rheum"},{"key":"1002_CR23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/rheumatology\/39.9.969","volume":"39","author":"HC Nossent","year":"2000","unstructured":"Nossent HC, Koldingsnes W (2000) Long-term efficacy of azathioprine treatment for proliferative lupus nephritis. Rheumatology 39:969\u2013974","journal-title":"Rheumatology"},{"key":"1002_CR24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00296-002-0236-5","volume":"23","author":"J Kaufmann","year":"2003","unstructured":"Kaufmann J, Schulze E, Voigt U et al (2003) Orbital inflammatory pseudo-tumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patients with atypical, cANCA-positive Wegener\u2019s granulomatosis. Rheumatol Int 23:138\u2013142","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"1002_CR25","first-page":"S30","volume":"3","author":"EG Seidmann","year":"2003","unstructured":"Seidmann EG (2003) Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord 3 [Suppl 1]:S30\u2013S38","journal-title":"Rev Gastroenterol Disord"},{"issue":"Suppl 1","key":"1002_CR26","first-page":"319","volume":"63","author":"PM Aries","year":"2004","unstructured":"Aries PM, Vosswinkel J, Hellmich B, Gross WL (2004) High-dose azathioprine pulse therapy as a new therapeutic option in refractory Wegener\u2019s granulomatosis. Ann Rheum Dis 63 [Suppl 1]:319","journal-title":"Ann Rheum Dis"},{"key":"1002_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"122","author":"DC Person","year":"1995","unstructured":"Person DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6- mercaptopurine in Crohn\u2019s disease: a meta-analysis. Ann Intern Med 122:132\u2013142","journal-title":"Ann Intern Med"},{"key":"1002_CR28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1365-2036.1999.00559.x","volume":"13","author":"DH Casson","year":"1999","unstructured":"Casson DH, Davies SE, Thompson MA et al (1999) Low-dose intravenous azathioprine may be effective in the management of acute fulminant colitis complicating inflammatory bowel disease. Aliment Pharmacol Ther 13:981\u2013995","journal-title":"Aliment Pharmacol Ther"},{"key":"1002_CR29","first-page":"138","volume":"59","author":"E Louis","year":"1998","unstructured":"Louis E, Dupont P, Depauw A et al (1998) Rapid anti-inflammatory effect on high dose azathioprine in inflammatory bowel disease: an in vitro study. Digestion 59:138","journal-title":"Digestion"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-1002-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1002-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:42:40Z","timestamp":1559119360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-1002-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,26]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-1002-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,26]]}}}